Malik AK, White SA, Mann DA. Comment on: Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: long-term efficacy and biomarker exploration. J Hepatol 2025 Oct 31:S0168-8278(25)02606-6. doi: 10.1016/j.jhep.2025.
PMID: 41177403